Diagnosis of hereditary haemochromatosis using non-invasive methods

Transfusion Medicine and Hemotherapy

Volumn 30, Issue 1, 2003, Pages 27-36

  Nielsen, P ^a,b   Fischer, R ^a   Engelhardt, R ^a   Dullmann J ^b  

^a Abteilung Molekulare Zellbiologie   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

C282Y mutation; H63D; Hereditary haemochromatosis; HFE gene; Iron overload; Liver iron concentration; MRI; S65C; Serum ferritin; SQUID biosusceptometry

Indexed keywords

ASPARTIC ACID; FERRITIN; HISTIDINE; IRON;

ALLELE; AMINO ACID SUBSTITUTION; CALIBRATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON ABSORPTION; IRON BLOOD LEVEL; IRON KINETICS; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; LIVER BIOPSY; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; REVIEW; SCREENING TEST; SIDEROSIS; SKIN PIGMENTATION;

EID: 0345491587     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069342     Document Type: Review

References (66)

1. Brock JH, Halliday JW, Pippard MJ, Powell LW (eds): Iron Metabolism in Health and Disease. London, Saunders, 1994.
2. Finch C, Huebers H: Perspectives in iron metabolism. N Engl J Med 1982;306:1520-1528.
3. Brittenham GM: The red cell cycle; in Brock JH, Halliday JW, Pippard MJ, Powell L W (eds): Iron Metabolism in Health and Disease. London, Saunders, 1994;31-62.
4. Andrews NC: Disorders of iron metabolism. N Engl J Med 1999;341:1986-1995.
5. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger M: Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997;388:482-488.
6. McKie AT, Martinai P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, W. Hentze MW, Simpson RJ: A novel duodenal iron-regulated transporter, IREC1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000;5:299-309.
7. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI: Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000;403:776-781.
8. Schümann K, Moret R, Kunzle H, Kuhn LC: Iron regulatory protein as an endogenous sensor of iron in rat intestinal mucosa: Possible implications for the regulation of iron absorption. Eur J Biochem 1999;260:362-372.
9. Finch C: Regulators of iron balance in humans. Blood 1994;84:1697-1702.
10. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K: LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147-150.
11. Park CH, Valore EV, Waring AJ, Ganz T: Hepcidin, a urinary antimircrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-7810.
12. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S: Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 2001;98:8780-8785.
13. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997;89:739-761.
14. Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, Gamberini MR, Sabato V, Melevendi C, Cappelini MD, Verlato G: Survival and disease complications in thalassemia major. Ann N Y Acad Sci 1998;850:227-231.
15. Nielsen P, Kordes U, Fischer R, Engelhardt R, Janke GE: SQUID-Biosuszeptometrie bei Eisenüberladungserkrankungen in der Hämatologie. Klin Pädiatr 2002;214:218-222.
16. Von Recklinghausen FD: Tageblatt der 62. Versammlung Deutscher Naturforscher und Ärzte in Heidelberg 1889:324-325.
17. Sheldon JH: Haemochromatosis, London, Oxford University Press, 1935.
18. Simon M, Alexandre JL, Bourel M, LeMarec B, Scordia C Heredity of idiopathic hemochromatosis: A study of 106 families. Clin Genet 1977;11:327-341.
19. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Qiuntana L, Starnes SM, Schatzmann RC, Brunke KJ, Drauna DT, Risch NJ, Bacon BR, Wolff RK: A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
20. Lebron JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA, Feder JN, Bjorkman PJ: Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998;93:111-123.
21. Waheed A, Parkkila S, Saarnio J, Fleming RE, Zhou XY, Tomatsu S, Britton RS, Bacon BR, Sly WS: Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci USA 1999;96:1579-1584.
22. Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, Fei Y, Brunt EM, Ruddy DA, Prass CE, Schatzman RC, O'Neill R, Britton RS, Bacon BR, Sly WS: HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998;95:2492-2497.
23. Santos M, Schilham MW, Rademakers LHPM, Marx JJM, De Sousa M, Clevers H: Defective iron homeostasis in β2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J Exp Med 1996;184:1975-1985.
24. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ: Global prevalence of putative haemochromatosis mutations. J Med. Genet 1997;34:275-278.
25. Gottschalk R, Seidl C, Löffler T, Seifried E, Hoelzer D, Kaltwasser JP: HFE codon 63/282 (H63D/C282Y) dimorphism in German patients with genetic hemochromatosis. Tissue Antigens 1998;51:270-275.
26. Nielsen P, Carpinteiro S, Fischer R, Cabeda JM, Porto G, Gabbe EE: Prevalence of the C282Y- and the H63D-mutations in the HFE-gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany. Br J Haematol 1998;103:842-845.
27. Nielsen P: Gendiagnostische Möglichkeiten der hereditären Härmochromatose; in Ganten D, Ruckpaul K (eds): Handbuch der Molekularen Medizin, Band 6: Monogen bedingte Erkrankungen. Berlin, Springer, 2000, pp 454-475.
28. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, Vergani A, Fraquelli M, Girelli D, Pasquero P, Roetto A, Gasparini P, Fargion S, Conte D, Camaschella C: Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998;114:996-1002.
29. Pointon JJ, Wallace D, Merryweather-Clarke AT: Uncommon mutations and polymorphisms in the hemochromatosis gene. Genet Test 2000;4:151-161.
30. Camaschella C, Roetto A, Ciciliano M, Pasquero P, Bosio S, Gubetta L, Di Vito F, Goncalves C, Girelli D, Totaro A, Carella M, Grifa A, Gasparini P: Juvenile and adult hemochromatosis are distinct genetic disorders. Eur J Hum Genet 1997;5:371-375.
31. Kaltwasser JP, Gottschalk R, Seidl CH: Severe juvenile haemochromatosis (JH) missing HFE gene variants: Implications for a second gene locus leading to iron overload. Br J Haematol 1998;102:1111-1122.
32. Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P: The gene TFR2 is mutated in a new type of haemochromatosis to 7q22. Nat Genet 2000;25:14-15.
33. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A: Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619-623.
34. Camaschella C, Fargion S, Sampietro M, Roetto A, Bosio S, Garozzo G, Arosio C, Piperno A: Inherited HFE-unrelated hemochromatosis in Italian families. Hepatology 1999;29:1563-1564.
35. Moyo VM, Mandishona E, Hasstedt SJ, Gangaidzo IT, Gomo ZAR, Khumalo H, Saungweme T, Kiire CF, Paterson AC, Bloom P, MacPhail AP, Rouault T, Gordeuk VR: Evidence of genetic transmission in African iron overload. Blood 1998;91:1076-1082.
36. Kniseley AS: Neonatal hemochromatosis. Adv Pediatr 1992;39:383-403.
37. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G: Survival and causes of death in cirrhotic and non-cirrhotic patients with primary haemochromatosis. N Engl J Med 1985;313:1256-1262.
38. Adams PC, Speechley M, Kertesz AE: Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101:368-372.
39. Adams PC, Deugnier Y, Moirand R, Brissot P: The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997;25:162-166.
40. Niederau C, Niederau CM, Lange S, Littauer A, Abdel-Jalil N, Mauere M, Häussinger D, Strohmeyer G: Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Intern Med 1998;128:337-345.
41. Nielsen P, Benn H-P, Peters C, Fischer R, Darda C, Knoedler B, Gabbe EE, Kuehnl P: Iron status in prospective blood donors. Infusionsther Transfusionsmed 1995;22(suppl 1):142-144.
42. Beutler E, Felitti VJ, Koziol JA, Ho JN, Gelbart T: Penetrance of 845G*A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002;359:211-218.
43. Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelonning K, Fjosne U, Halvorsen TB, Smethurst HB, Sagen E, Bjerve KS: Screening for hemochromatosis: High prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108-1115.
44. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA: Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200.
45. Aruoma OI, Bomford A, Polson RJ, Halliwell B: Non-transferrin-bound iron in plasma from hemochromatosis patients: Effect of phlebotomy therapy. Blood 1988;72:1416-1419.
46. Walters GO, Miller FM, Woorwood M: Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 1973;26:770-772.
47. Nielsen P, Engelhardt R, Duerken M, Janka GE, Fischer R: Using SQUID biomagnetic liver susceptometry in the treatment of thalassaemia and other iron loading diseases. Transfus Sci 2000;23:257-258.
48. Herbert V, Jayatilleke E, Shaw S, Rosman AS, Giardina P, Grady RW, Bowman B, Gunter EW: Serum ferritin iron, a new ts WC: Iron in the heart. Etiology and clinical significance. Am J Med 1971;51:209-221.
49. Düllmann J, Wulfhekel U, Mohr A, Riecken K, Hausmann K: Absence of macrophage and presence of plasmacellular iron storage in the terminal duodenum of patients of patients with hereditary haemochromatosis. Virchows Arch A Pathol Anat Histopathol 1991;418:241-247.
50. Powell LW: Primary iron overload; in Brock JH, Halliday JW, Pippard MJ, Powell LW (eds): Iron Metabolism in Health and Disease. London, Saunders, 1994, pp 227-270.
51. Brissot P, Bourel M, Herry D, Verger JP, Messner M, Beaumont C, Regnouard F, Ferrand B, Simon M: Assessment of liver iron content in 271 patients: A reevaluation of direct and indirect methods. Gastroenterology 1981;80:557-565.
52. Bassett ML, Halliday JW, Powell LW: Value of hepatic iron measurement in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986;6:24-29.
53. Camaschella C, De Gobbi M, Roetto A: Hereditary hemochromatosis: Progress and perspectives. Rev Clin Exp Hematol 2000;4:302-321.
54. Guyader D, Gandon Y, Deugnier Y, Jouanolle H, Loreal O, Simon M, Bourel M, Carsin M, Brissot P: Evaluation of computed tomography in the assessment of liver iron overload. A study of 46 cases of idiopathic hemochromatosis. Gastroenterology 1989;97:737-743.
55. Kaltwasser JP, Gottschalk R, Schalk KP, Hartl W: Non-invasive quantification of liver iron-overload by magnetic resonance imaging. Br J Haematol 1990;74:360-363.
56. Engelhardt R, Langkowski JH, Fischer R, Nielsen P, Kooijman H, Heinrich HC, Bücheler E: Liver iron quantification: Studies in aqueous iron solutions, iron overloaded rats and patients with hereditary hemochromatosis. Magn Reson Imaging 1994;12:999-1007.
57. Jensen PD, Jensen FT, Christensen T, Ellegard J: Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol 1994;87:171-184.
58. Clark PR, St. Pierre TG: Quantitative mapping of transverse relaxivity (1/T) in hepatic iron overload: A single spin-echo imaging methodology. Magn Reson Imaging 2000;18:431-438.
59. Fischer R, Engelhardt R, Heinrich HC, Kessler M, Nielsen P: The calibration problem in liver iron susceptometry; in Williamson SJ, Hoke M, Stroink G, Kotani M (eds): Advances in Biomagnetism. New York, Plenum, 1989, pp 501-504.
60. Fischer R: Liver iron susceptometry; in Andrä W, Nowak H (eds): Magnetism in Medicine. Berlin, Wiley-VCH, 1998, pp 286-301.
61. Nielsen P, Fischer R, Engelhardt R, Dresow B, Gabbe EE: Neue Möglichkeiten in der Diagnose der hereditären Hämochromatose. Dtsch Ärztebl 1998;95:A2912-2921.
62. Mura C, Raguenes O, Ferec C: HFE mutations analysis in 711 hemochromatosis probands: Evidence for S65C implication in mild form of he-mochromatosis. Blood 1998;99:2502-2505.
63. Adams P, Brissot P, Powell LW: EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000;33:485-504.
64. Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC, Barton JC, Beutler E, Brittenham G, Buchanan A, Clayton EW, Cogswell ME, Meslin EM, Motulsky AG, Powell LW, Sigal E, Wilfond BS, Collins FS: Hereditary hemochromatosis: Gene discovery and its implications for population-based screening. JAMA 1998;280:172-178.
65. Haddow JE, Bradley LA. Hereditary haemochromatosis: To screen or not. Conditions for screening are not yet fulfilled (editorial). BMJ 1999;319:531-532.
66. Phatak PD, Guzman G, Woll JE, Robeson A, Phelps CE: Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med 1994;154:769-776.